Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 14 September 1979:
Vol. 205. no. 4411, pp. 1163 - 1164
DOI: 10.1126/science.472735
Prev | Table of Contents | Next

Articles

Science, Vol 205, Issue 4411, 1163-1164
Copyright © 1979 by American Association for the Advancement of Science

articles

Plasma beta-endorphin immunoreactivity in schizophrenia

M Ross, PA Berger, and A Goldstein

Plasma beta-endorphin-like immunoreactivity was measured by a method that was equally sensitive to beta-endorphin and [Leu5]-beta-endorphin. Immunoreactivity in 98 schizophrenic patients did not differ greatly from that in 42 normal subjects. No immunoreactivity was detectable in dialyzates from first-time hemodialysis of eight nonpsychotic renal patients and nine schizophrenic patients. These results are not compatible with recent reports of extremely high concentrations of [Leu5]-beta-endorphin in hemodialyzates from schizophrenic patients.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Diversity of Neurologic Events in Systemic Lupus Erythematosus: Prospective Clinical and Computed Tomographic Classification of 82 Events in 71 Patients.
A. T. Kaell, M. Shetty, B. C. P. Lee, and M. D. Lockshin (1986)
Arch Neurol 43, 273-276
   Abstract »    PDF »
Dialysis in schizophrenia: a double-blind evaluation.
S. Schulz, D. van Kammen, J. Balow, M. Flye, and W. Bunney Jr (1981)
Science 211, 1066-1068
   Abstract »    PDF »
{beta}-Endorphin: Intravenous Infusion Causes Behavioral Change in Psychiatric Inpatients.
R. H. Gerner, D. H. Catlin, D. A. Gorelick, K. K. Hui, and C. H. Li (1980)
Arch Gen Psychiatry 37, 642-647
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)